Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Zepp Health (ZEPP) EBIAT (2016 - 2025)

Zepp Health has reported EBIAT over the past 10 years, most recently at -$11.0 million for Q4 2025.

  • For Q4 2025, EBIAT rose 70.27% year-over-year to -$11.0 million; the TTM value through Dec 2025 reached -$40.1 million, up 47.14%, while the annual FY2025 figure was -$38.0 million, 46.93% up from the prior year.
  • EBIAT for Q4 2025 was -$11.0 million at Zepp Health, down from -$1.6 million in the prior quarter.
  • Over five years, EBIAT peaked at $14.3 million in Q2 2021 and troughed at -$36.9 million in Q4 2024.
  • A 5-year average of -$8.4 million and a median of -$10.4 million in 2024 define the central range for EBIAT.
  • Biggest five-year swings in EBIAT: soared 615.87% in 2021 and later crashed 3547.4% in 2024.
  • Year by year, EBIAT stood at $5.7 million in 2021, then tumbled by 293.64% to -$11.0 million in 2022, then soared by 88.49% to -$1.3 million in 2023, then crashed by 2819.38% to -$36.9 million in 2024, then surged by 70.27% to -$11.0 million in 2025.
  • Business Quant data shows EBIAT for ZEPP at -$11.0 million in Q4 2025, -$1.6 million in Q3 2025, and -$7.7 million in Q2 2025.